Filing Details
- Accession Number:
- 0001209191-10-044888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-02 16:30:14
- Reporting Period:
- 2010-08-31
- Filing Date:
- 2010-09-02
- Accepted Time:
- 2010-09-02 16:30:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 858803 | Avanir Pharmaceuticals Inc. | AVNR | Pharmaceutical Preparations (2834) | 330314804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314596 | Keith Katkin | 101 Enterprise, Suite 300 Aliso Viejo CA 92656 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-31 | 40,000 | $2.86 | 230,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-09-01 | 62,874 | $2.83 | 167,173 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2010 and a majority of the proceeds from such sales were used to pay required tax withholdings due upon vesting of restricted stock units previously granted to the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.8400 to $2.8817, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.8100 to $2.8624, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
